Drug intelligence / Profile preview

M051

Development stage
Preclinical
Lead developer
M6P Therapeutics
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

M051 is a preclinical-stage enzyme replacement therapy (ERT) being developed by M6P Therapeutics for the treatment of Fabry disease. It consists of a recombinant human alpha-galactosidase A (GLA) enzyme. M6P Therapeutics utilizes a proprietary platform to enhance the phosphorylation of the enzyme, specifically increasing the levels of mannose-6-phosphate (M6P) residues. This modification is designed to improve the enzyme's binding to M6P receptors on the cell surface, thereby facilitating more efficient cellular uptake and trafficking to the lysosomes. Once inside the lysosome, the enzyme restores the activity needed to degrade accumulated globotriaosylceramide (Gb3), addressing the underlying cause of Fabry disease.

02

Targets

Gb3 (Globotriaosylceramide)IGF2R (Cation-independent mannose-6-phosphate receptor)GLA (Alpha-galactosidase A)

Beyond the preview

Go deeper on M051.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on M051.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call